The Relationship Between Inflammatory Biomarkers and Symptom Distress in Lung Cancer Patients Undergoing Chemotherapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Nursing

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/NCC.0000000000000369PMID 27044062
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Symptom Experience in Older Adults Undergoing Treatment for Cancer

  2018cited by this paper
• Protein Kinase C Inhibitor, GF109203X Attenuates Osteoclastogenesis, Bone Resorption and RANKL‐Induced NF‐κB and NFAT Activity

  2015cited by this paper
• Symptom Experience in Older Adults Undergoing Treatment for Cancer.

  2015cited by this paper
• The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexia.

  2015cited by this paper
• Predictors of symptom experience in Korean patients with cancer undergoing chemotherapy.

  2015cited by this paper
• A longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer.

  2015cited by this paper
• Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study†

  2015cited by this paper
• 410PWho is a cancer survivor? a study into the lay understanding of cancer identity using a crowdsourced population

  2015cited by this paper
• The Calcineurin Inhibitor Tacrolimus as a New Therapy in Severe Cherubism

  2015cited by this paper
• Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression

  2015cited by this paper
• Discovery of 5-(2',4'-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis.

  2015cited by this paper
• Role of TGF‐β in a Mouse Model of High Turnover Renal Osteodystrophy

  2014cited by this paper
• Characteristics and effectiveness of complex nursing interventions aimed at reducing symptom burden in adult patients treated with chemotherapy: a systematic review of randomized controlled trials.

  2014cited by this paper
• Tartrate-resistant acid phosphatase 5a in sarcoidosis: further evidence for a novel macrophage biomarker in chronic inflammation.

  2014cited by this paper
• Coenzyme q10 regulates osteoclast and osteoblast differentiation.

  2013cited by this paper
• Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.

  2013cited by this paper
• C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy.

  2013cited by this paper
• Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer Patients

  2012cited by this paper
• Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: a secondary analysis.

  2012cited by this paper
• Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.

  2012cited by this paper
• Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.

  2012cited by this paper
• The Role of Thalidomide and Placebo for the Treatment of Cancer-Related Anorexia-Cachexia Symptoms: Results of a Double-Blind Placebo-Controlled Randomized Study

  2012cited by this paper
• Symptom trajectories during chemotherapy in outpatients with lung cancer colorectal cancer, or lymphoma.

  2011cited by this paper
• Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?

  2011cited by this paper
• Methodologic Issues in the Measurement of Cytokines to Elucidate the Biological Basis for Cancer Symptoms

  2011cited by this paper
• I’m so tired: biological and genetic mechanisms of cancer-related fatigue

  2010cited by this paper
• Pilot study of cranial stimulation for symptom management in breast cancer.

  2010cited by this paper
• Serial changes of cytokines in active ulcerative colitis: effects of antibiotic combination therapy.

  2009cited by this paper
• Biology and Clinical Significance of Tartrate-Resistant Acid Phosphatases: New Perspectives on an Old Enzyme

  2009cited by this paper
• Imaging , Diagnosis , Prognosis Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer

  2009cited by this paper
• Significance of Serum TRACP in Rheumatoid Arthritis

  2008cited by this paper
• Cytokines and their relationship to the symptoms and outcome of cancer

  2008cited by this paper
• Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy.

  2008cited by this paper
• Mechanisms of cancer-related fatigue.

  2007cited by this paper
• Tartrate-resistant acid phosphatase as an immunohistochemical marker for inflammatory macrophages.

  2007cited by this paper
• Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines.

  2006cited by this paper
• Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.

  2005cited by this paper
• Properties and expression of human tartrate‐resistant acid phosphatase isoform 5a by monocyte‐derived cells

  2005cited by this paper
• Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients.

  2004cited by this paper
• Levels of Fatigue Compared to Levels of Cytokines and Hemoglobin during Pelvic Radiotherapy: a Pilot Study

  2004cited by this paper
• Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients.

  2004cited by this paper
• Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia1

  2002cited by this paper
• Changes in monocyte phagocyting activity after multi-agent chemotherapy in non-small cell lung cancer.

  2002cited by this paper
• Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer.

  2001cited by this paper
• Psychometric testing of fatigue instruments for use with cancer patients.

  2000cited by this paper
• Tartrate‐Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone Resorption

  2000cited by this paper
• Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.

  1996cited by this paper
• Pain and its treatment in outpatients with metastatic cancer.

  1994cited by this paper
• Changes in enzyme expression related to differentiation and regulatory factors: the acid phosphatase of osteoclasts and other macrophages.

  1992cited by this paper
• Research in cancer pain. What we know and what we need to know

  1991cited by this paper
• Performance status assessment in cancer patients

  1990cited by this paper
• The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

  1989cited by this paper
• Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastomas.

  1989cited by this paper
• A shortened version of the Profile of Mood States.

  1983cited by this paper
• Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children.

  1978cited by this paper
• Manual for the Profile of Mood States

  1971cited by this paper

• Cytokine–Cytokine Receptor Interaction and Endocytosis are Common Pathways for Symptom Burden and Sickness Behavior Symptoms in Oncology Patients Undergoing Chemotherapy

  2025cites this paper
• Nonpharmacological Interventions for the Fatigue-Pain-Sleep Disturbance Symptom Cluster in Lung Cancer Patients: Best Evidence Summary.

  2024cites this paper
• Neurodegenerative disease pathways are perturbed in patients with cancer who self‐report cognitive changes and anxiety: A pathway impact analysis

  2024cites this paper
• Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison

  2023cites this paper
• Comparing the sensitivity of fatigue and sleep disturbance assessment tools in women with advanced cancer undergoing chemotherapy

  2023cites this paper
• Effect of cancer treatment on sleep quality in cancer patients: A systematic review and meta-analysis of Pittsburgh Sleep Quality Index

  2022cites this paper
• The Association Between Sleep Disturbance and Proinflammatory Markers in Patients With Cancer

  2022cites this paper
• STOP Pain Project—Opioid Response in Pediatric Cancer Patients and Gene Polymorphisms of Cytokine Pathways

  2022cites this paper
• Cancer‐related inflammation and depressive symptoms: Systematic review and meta‐analysis

  2022cites this paper
• Blood-Based Biomarkers of Cancer-Related Cognitive Impairment in Non-Central Nervous System Cancer: A Scoping Review.

  2022cites this paper
• P2X Receptors: Potential Therapeutic Targets for Symptoms Associated With Lung Cancer — A Mini Review

  2021cites this paper
• Serum tumor necrosis factor‐α, interleukin‐1β, interleukin‐6, and interleukin‐17 relate to anxiety and depression risks to some extent in non‐small cell lung cancer survivor

  2021cites this paper
• Symptom Clusters Change Over Time in Patients With Lung Cancer During Perichemotherapy

  2020cites this paper
• A Longitudinal Analysis of Inflammation and Depression in Patients With Metastatic Lung Cancer: Associations With Survival

  2020cites this paper
• Periodontal disease, sleep duration and white blood cell markers in the 2009-2014 national health and nutrition examination surveys.

  2019cites this paper
• Are Perceived Stress and Cytokine Genotypes Clinically Feasible as Predictors of Psychoneuroimmune Symptoms in Advanced Cancer?

  2019cites this paper
• Psychological correlates of sleep quality in lung cancer patients under chemotherapy: A single‐center cross‐sectional study

  2019cites this paper
• Chemotherapy agents induce tartrate‐resistant acid phosphatase 5a contributing to the symptom distress in lung cancer patients

  2019cites this paper
• The risk factors for depression in cancer patients undergoing chemotherapy: a systematic review

  2018cites this paper